"Scrutiny of AI by Healthcare Regulatory Agencies," AI Across Industries, Davis Wright Tremaine Webinar

As AI-enabled solutions multiply in the marketplace, healthcare regulators feel an increasing sense of urgency to put guardrails on the development and implementation of these solutions. To do so requires a look at the existing regulatory framework for innovations in healthcare and where new paths can be forged for AI and machine learning.

In this webinar, Kristen Klesh explores the consideration of AI as a medical device from an FDA regulatory perspective. Gavin Keene discusses the regulation of AI by healthcare regulatory bodies including the Center for Medicare & Medicaid Services (CMS) and state medical boards.

Presenters

• Gavin Keene, Associate, Davis Wright Tremaine
• Kristen Klesh, Partner, Loeb & Loeb

This webinar is the fourth in DWT's webinar series "AI Across Industries," a monthly webinar examining legal risks, challenges, and opportunities presented by the adoption of AI/ML in healthcare, financial services, media, technology, communications, and other leading industries.